Event Datetime
2019.03.16 (Sat) 13:00-14:40 (GMT+8)Event Location
Room 803, International Convention Center, Chang Yung-Fa Foundation
Near by MRT National Taiwan University Hospital Station, Exit2Organizer
SynCore Biotechnology Co. Ltd
Advanced Pancreatic cancer (PC) is well-known for high mortality and low survival rate. Among existing treatments and regimens, FOLFIRINOX is one of the primary and dominant regimens for clinical use. This forum invites physicians to share valuable experience in FOLFIRINOX application.
Information
Guests
Moderator
Dr. Li-Tzong ChenDr. Li-Tzong Chen
Director of National Institute of Cancer Research, National Health Research Institutes, Taiwan
Specialities: Medical Oncology, Gastroenterology, Experimental therapy and Translational Research
Moderator
JUNJI FURUSE M.D., Ph D.JUNJI FURUSE M.D., Ph D.
Department of Medical Oncology, Kyorin University School of Medicine, Japan
Specialities: Chemotherapies in Hepatobiliary, Pancreatic and Other Digestive Cancers
Speaker
TAKUJI OKUSAKA M.D., Ph D.TAKUJI OKUSAKA M.D., Ph D.
Department of Hepatobiliary and Pancreatic Oncology, national Cancer Center Hospital, Japan
Specialties: Liver, Biliary system and Pancreatic Cancers
Speaker
Dr. Nai-Jung ChiangDr. Nai-Jung Chiang
Attending Physician, National Institute of Cancer Research, NHRI; and Division of Oncology-Hematology, Department of internal medicine, National Cheng Kung University Hospital, Taiwan
Specialties: Solid tumors, GIST and Biliary tract cancer
Attendee
Suitable for attendees include attending physicians, residents and clinically relevant professionals.
Registration
This form is currently closed for submissions.
Notes
- The success of registration will be confirmed by phone.
- Due to quota limitation, the organizer may close the online registration at any time and retain final right of registration qualification.
- The organizer reserves the right for agenda and speaker modification due to any reasons of force majeure.